Clinical Trials Browser

Dizziness, Migraine Disorders, Motion Sickness, Neuroma, Acoustic, Vestibular Diseases

NCT06929468 2025-04-16

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Deafness, Dizziness, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Vestibular Diseases, Hearing Loss

NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Completed

1,149 enrolled

Head & NeckLymphoidOther hematologic neoplasm

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

Clinical Trials

Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)